Category: Travelers Dominion Travelers Dominion
Perhaps only the British would create a jibe about a jab, but the "Oxford Jab" is a go. Matt Hancock, Secretary of State for Health of the United Kingdom, announced approval of the SARS-CoV-2 vaccine produced by Oxford University and pharmaceutical firm AstraZeneca. The one hundred million doses will vaccinate at least fifty million people in the UK as it presently requires two injections. There is some early suggestion from early results during testing prior to approval that a single dose may be enough however for now two will be the norm. This is a key point to consider as a single does regime would double the effective production capacity. The Oxford Jab also is welcome tool in the fight against COVID-19 because it requires conventional and common refrigeration, verse the unusually low temperatures the vaccines now entering use in the United States. It is expected that future iterations of all vaccines in development will require progressively less delicate handling however and likely fewer does eventually.